Follow the HLS Therapeutics Inc. stock price and the full insider trade history of the company, a publicly traded company based in Canada. Shares trade on the CA market, under the authority of SEDI. Market capitalisation: €117.2m. The latest transaction was disclosed on 1 September 2026 (38 - Redemption, retraction, cancellation, repurchase). Among the most active insiders: HLS Therapeutics Inc.. Every trade is openly available.
76
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
8Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 17,801 of 29,062 companies
45.1
score / 100
Value
53
Quality
38
FCF yld13%
Earn yld-11%
EV/EBITDA10.4x
ROE-14%
Gross mgn82%
Net mgn-22%
Debt/EBITDA3.1x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.